AI-enabled technology independently predicts cardiac events based on coronary inflammation healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.
Researchers from the University of Oxford have reported findings from a Phase 2 clinical trial investigating the efficacy of an investigational treatment against long COVID fatigue.The study (reported in Lancet eClinical Medicine) found participants given the treatment, developed by US pharmaceutical company Axcella Therapeutics, reported feeling less fatigued than those given
This is one of the first randomized double-blind placebo controlled trials of a potential long COVID treatment - AXA1125. Randomised control trials are considered to be gold standard. | April 14, 2023
Long COVID fatigue treatment trial reveals results miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.